Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Ramaekers

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The British Journal of Radiology|August 8, 2017
What is the impact of innovation on output in healthcare with a special focus on treatment innovations in radiotherapy? A literature reviewMaria Jacobs, Liesbeth Boersma, Andre Dekker, et al.
Pharmacoeconomics|November 8, 2014
A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosisMickaël Hiligsmann, Silvia M Evers, Wafa Ben Sedrine, et al.
Cancers|June 2, 2021
Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an <i>In Silico</i> Clinical Trial and a Cost-Utility StudyYvonka van Wijk, Bram Ramaekers, Ben G L Vanneste, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2026
Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancerDiego Larrotta-Castillo, Yi Hsuan Chen, Luuk van der Hoek, et al.
The International Journal of Cardiovascular Imaging|February 17, 2023
A graphical analysis of aspects contributing to the spreading of measurements of left ventricular functionChristian Knackstedt, Georg Schummers, Jörg Schröder, et al.
Pharmacoeconomics|October 27, 2022
Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBen Wijnen, Willem Witlox, Robert Wolff, et al.
Pharmacoeconomics|June 10, 2020
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBen Wijnen, Nigel Armstrong, Bram Ramaekers, et al.
Pharmacoeconomics|April 13, 2024
A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel ConsultationsJunfeng Wang, Xavier Pouwels, Bram Ramaekers, et al.
Journal of Telemedicine and Telecare|December 19, 2017
Telemonitoring in patients with heart failure: Is there a long-term effect?Arno J Gingele, Hanspeter Brunner-la Rocca, Bram Ramaekers, et al.
Pharmacoeconomics|January 9, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted TherapyZakile A Mfumbilwa, Martijn J H G Simons, Bram Ramaekers, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The British Journal of Radiology|August 8, 2017
What is the impact of innovation on output in healthcare with a special focus on treatment innovations in radiotherapy? A literature reviewMaria Jacobs, Liesbeth Boersma, Andre Dekker, et al.
Pharmacoeconomics|November 8, 2014
A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosisMickaël Hiligsmann, Silvia M Evers, Wafa Ben Sedrine, et al.
Cancers|June 2, 2021
Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an <i>In Silico</i> Clinical Trial and a Cost-Utility StudyYvonka van Wijk, Bram Ramaekers, Ben G L Vanneste, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2026
Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancerDiego Larrotta-Castillo, Yi Hsuan Chen, Luuk van der Hoek, et al.
The International Journal of Cardiovascular Imaging|February 17, 2023
A graphical analysis of aspects contributing to the spreading of measurements of left ventricular functionChristian Knackstedt, Georg Schummers, Jörg Schröder, et al.
Pharmacoeconomics|October 27, 2022
Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBen Wijnen, Willem Witlox, Robert Wolff, et al.
Pharmacoeconomics|June 10, 2020
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBen Wijnen, Nigel Armstrong, Bram Ramaekers, et al.
Pharmacoeconomics|April 13, 2024
A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel ConsultationsJunfeng Wang, Xavier Pouwels, Bram Ramaekers, et al.
Journal of Telemedicine and Telecare|December 19, 2017
Telemonitoring in patients with heart failure: Is there a long-term effect?Arno J Gingele, Hanspeter Brunner-la Rocca, Bram Ramaekers, et al.
Pharmacoeconomics|January 9, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted TherapyZakile A Mfumbilwa, Martijn J H G Simons, Bram Ramaekers, et al.
Pageof 4